These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 36708302)
1. Contrast-enhanced ultrasound pattern of hepatocellular carcinoma in noncirrhotic liver - results from the prospective multicentre DEGUM CEUS HCC study. Schellhaas B; Jesper D; Strobel D; Eur J Gastroenterol Hepatol; 2023 Mar; 35(3):313-319. PubMed ID: 36708302 [TBL] [Abstract][Full Text] [Related]
2. Real-life assessment of standardized contrast-enhanced ultrasound (CEUS) and CEUS algorithms (CEUS LI-RADS®/ESCULAP) in hepatic nodules in cirrhotic patients-a prospective multicenter study. Strobel D; Jung EM; Ziesch M; Praktiknjo M; Link A; Dietrich CF; Klinger C; Schultheiß M; Jesper D; Schellhaas B Eur Radiol; 2021 Oct; 31(10):7614-7625. PubMed ID: 33855588 [TBL] [Abstract][Full Text] [Related]
3. LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations. Schellhaas B; Wildner D; Pfeifer L; Goertz RS; Hagel A; Neurath MF; Strobel D Ultraschall Med; 2016 Dec; 37(6):627-634. PubMed ID: 27486793 [No Abstract] [Full Text] [Related]
4. Washout appearance of hepatocellular carcinomas using standardized contrast-enhanced ultrasound (CEUS) including an extended late phase observation - Real-world data from the prospective multicentre DEGUM study. Meitner-Schellhaas B; Jesper D; Goertz RS; Zundler S; Strobel D Clin Hemorheol Microcirc; 2023; 84(4):413-424. PubMed ID: 37334585 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS. Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394 [TBL] [Abstract][Full Text] [Related]
6. Contrast-Enhanced Ultrasound Algorithms (CEUS-LIRADS/ESCULAP) for the Noninvasive Diagnosis of Hepatocellular Carcinoma - A Prospective Multicenter DEGUM Study. Schellhaas B; Bernatik T; Bohle W; Borowitzka F; Chang J; Dietrich CF; Dirks K; Donoval R; Drube K; Friedrich-Rust M; Gall C; Gittinger F; Gutermann M; Haenle MM; von Herbay A; Ho CH; Hochdoerffer R; Hoffmann T; Hüttig M; Janson C; Jung EM; Jung N; Karlas T; Klinger C; Kornmehl A; Kratzer W; Krug S; Kunze G; Leitlein J; Link A; Lottspeich C; Marano A; Mauch M; Moleda L; Neesse A; Petzold G; Potthoff A; Praktiknjo M; Rösner KD; Schanz S; Schultheiß M; Sivanathan V; Stock J; Thomsen T; Vogelpohl J; Vogt C; Wagner S; Wiegard C; Wiesinger I; Will U; Ziesch M; Zimmermann P; Strobel D Ultraschall Med; 2021 Apr; 42(2):178-186. PubMed ID: 32663881 [TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced ultrasound Liver Imaging Reporting and Data System: Lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis. Vidili G; Arru M; Solinas G; Calvisi DF; Meloni P; Sauchella A; Turilli D; Fabio C; Cossu A; Madeddu G; Babudieri S; Zocco MA; Iannetti G; Di Lembo E; Delitala AP; Manetti R World J Gastroenterol; 2022 Jul; 28(27):3488-3502. PubMed ID: 36158272 [TBL] [Abstract][Full Text] [Related]
8. Interobserver Agreement for Contrast-Enhanced Ultrasound (CEUS)-Based Standardized Algorithms for the Diagnosis of Hepatocellular Carcinoma in High-Risk Patients. Schellhaas B; Pfeifer L; Kielisch C; Goertz RS; Neurath MF; Strobel D Ultraschall Med; 2018 Dec; 39(6):667-674. PubMed ID: 29879746 [TBL] [Abstract][Full Text] [Related]
9. Interobserver and intermodality agreement of standardized algorithms for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS. Schellhaas B; Hammon M; Strobel D; Pfeifer L; Kielisch C; Goertz RS; Cavallaro A; Janka R; Neurath MF; Uder M; Seuss H Eur Radiol; 2018 Oct; 28(10):4254-4264. PubMed ID: 29675659 [TBL] [Abstract][Full Text] [Related]
10. Contrast-Enhanced Ultrasound Patterns for the Non-invasive Diagnosis of Hepatocellular Carcinoma: A Prospective Multicenter Study in Histologically Proven Liver Lesions in a Real-Life Setting Demonstrating the Benefit of Extended Late Phase Observation. Schellhaas B; Bernatik T; Dirks K; Jesper D; Mauch M; Potthoff A; Zimmermann P; Strobel D Ultrasound Med Biol; 2021 Nov; 47(11):3170-3180. PubMed ID: 34417066 [TBL] [Abstract][Full Text] [Related]
11. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules. Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F; J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247 [TBL] [Abstract][Full Text] [Related]
12. Performance of current versus modified CEUS LI-RADS in the diagnosis of non-hepatocellular carcinoma malignancies. Wen R; Huang F; Lin P; Gao R; Pang J; Wu Y; Yin H; Tang Z; Ma Z; He Y; Yang H Abdom Radiol (NY); 2023 Dec; 48(12):3688-3695. PubMed ID: 37726380 [TBL] [Abstract][Full Text] [Related]
13. CEUS in hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in 320 patients - early or late washout matters: a subanalysis of the DEGUM multicenter trial. Wildner D; Bernatik T; Greis C; Seitz K; Neurath MF; Strobel D Ultraschall Med; 2015 Apr; 36(2):132-9. PubMed ID: 25812115 [TBL] [Abstract][Full Text] [Related]
14. Can contrast enhanced ultrasound differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma? Huang JY; Li JW; Ling WW; Li T; Luo Y; Liu JB; Lu Q World J Gastroenterol; 2020 Jul; 26(27):3938-3951. PubMed ID: 32774068 [TBL] [Abstract][Full Text] [Related]
15. Contrast-Enhanced Ultrasound for Differentiation Between Poorly Differentiated Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. Guo HL; Zheng X; Cheng MQ; Zeng D; Huang H; Xie XY; Lu MD; Kuang M; Wang W; Xian MF; Chen LD J Ultrasound Med; 2022 May; 41(5):1213-1225. PubMed ID: 34423864 [TBL] [Abstract][Full Text] [Related]
16. LR-M Observations on Contrast-Enhanced Ultrasound: Detection of Hepatocellular Carcinoma Using Additional Features in Comparison With Current LI-RADS Criteria. Xian MF; Huang Y; Xie WX; Pan KM; Zeng D; Huang H; Li MD; Xie XY; Kuang M; Lu MD; Chen LD; Wang W AJR Am J Roentgenol; 2022 Jul; 219(1):76-85. PubMed ID: 34910538 [No Abstract] [Full Text] [Related]
17. Contrast-enhanced ultrasound (CEUS) for differentiating between hepatocellular and cholangiocellular carcinoma. Bohle W; Clemens PU; Heubach T; Zoller WG Ultraschall Med; 2012 Dec; 33(7):E191-E195. PubMed ID: 22194045 [TBL] [Abstract][Full Text] [Related]
18. HCCs lacking arterial phase hyperenhancement (APHE) on contrast-enhanced ultrasound (CEUS) - a diagnostic challenge. Findings from the prospective multicenter DEGUM CEUS HCC trial. Strobel D; Agaimy A; Jesper D; Zundler S; Schellhaas B Ultraschall Med; 2023 Dec; 44(6):606-613. PubMed ID: 36781161 [TBL] [Abstract][Full Text] [Related]
19. Differentiation of intrahepatic cholangiocarcinoma from hepatocellular carcinoma in high-risk patients: A predictive model using contrast-enhanced ultrasound. Chen LD; Ruan SM; Liang JY; Yang Z; Shen SL; Huang Y; Li W; Wang Z; Xie XY; Lu MD; Kuang M; Wang W World J Gastroenterol; 2018 Sep; 24(33):3786-3798. PubMed ID: 30197484 [TBL] [Abstract][Full Text] [Related]
20. Pathological considerations of CEUS LI-RADS: correlation with fibrosis stage and tumour histological grade. Cheng MQ; Hu HT; Huang H; Pan JM; Xian MF; Huang Y; Kuang M; Xie XY; Li W; Wang W; Lu MD Eur Radiol; 2021 Aug; 31(8):5680-5688. PubMed ID: 33502556 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]